文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

非工作时间急性胆囊切除术的结局:系统评价与Meta分析

Outcomes following out-of-hours acute cholecystectomy: A systematic review and meta-analysis.
PubMed 文献 · J Trauma Acute Care Surg · 2022-01-01
一句话结论系统评价与Meta分析显示,非工作时间与工作时间急性胆囊切除术在总体及特定并发症风险上无差异,但无急性外科单元中心非工作时间手术转换率更高。

该系统评价与Meta分析比较非工作时间(夜间、周末)与工作时间(工作日日间)急性胆囊切除术的结局,纳入11项研究。结果显示胆漏、胆管损伤、总体术后并发症、中转开腹、手术时长、再入院、死亡及术后住院时间均无差异。单因素Meta分析中非工作时间术后脓毒症(OR 1.58,95%CI 1.04-2.41,P=0.03)和肺炎(OR 1.55,95%CI 1.06-2.26,P=0.02)发生率更高,但多因素校正后不再显著。无急性外科单元的中心非工作时间手术中转开腹率更高。

要点

  • 非工作时间与工作时间急性胆囊切除术在胆漏、胆管损伤、总体并发症、中转开腹、再入院、死亡及术后住院时间上无差异。
  • 单因素分析非工作时间术后脓毒症OR 1.58(95%CI 1.04-2.41,P=0.03)、肺炎OR 1.55(95%CI 1.06-2.26,P=0.02)更高,多因素校正后不再显著。
  • 无急性外科单元的中心行非工作时间急性胆囊切除术时中转开腹率更高。
  • 证据等级为系统评价与Meta分析,Level IV。

适用人群与场景

  • 成人任何急性良性胆囊疾病行急性胆囊切除术者。

研究设计与关键结果

  • 系统评价与Meta分析纳入11项比较非工作时间与工作时间急性胆囊切除术的研究。
  • 胆漏、胆管损伤、总体术后并发症、中转开腹、手术时长、再入院、死亡及术后住院时间在非工作时间与工作时间之间无差异。
  • 单因素Meta分析显示非工作时间术后脓毒症发生率更高(OR 1.58,95%CI 1.04-2.41,P=0.03),肺炎发生率更高(OR 1.55,95%CI 1.06-2.26,P=0.02),但多因素校正Meta分析后不再显著。
  • 在无急性外科单元的中心,非工作时间胆囊切除术的中转开腹率更高。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,证据等级Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来研究应评估医院结构性因素(如急性外科单元)对非工作时间急性胆囊切除术结局的潜在影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cholecystectomy is one of the most commonly performed abdominal operations. Rising demands on acute operating theater availability and resource utilization in the daytime have led to acute cholecystectomy being performed out-of-hours (in the evenings, at night, or on weekends), although it remains unknown whether outcomes differ between out-of-hours and in-hours (during the daytime on weekdays) acute cholecystectomy. This systematic review and meta-analysis aimed to compare outcomes following out-of-hours versus in-hours acute cholecystectomy.

METHODS: The study protocol was prospectively registered on PROSPERO (ID: CRD42021226127). MEDLINE, EMBASE, and Scopus databases were systematically searched for studies comparing outcomes following out-of-hours and in-hours acute cholecystectomy in adults with any acute benign gallbladder disease. The outcomes of interest were rates of bile leakage, bile duct injury, overall postoperative complications, conversion to open cholecystectomy, specific intraoperative and postoperative complications, length of stay, readmission, and mortality. Subgroup (evening/night-time vs. daytime, weekend vs. weekday, acute surgical unit [ASU]-only, non-ASU, and laparoscopic-only) and sensitivity analyses of adjusted multivariate regression analysis results was also performed.

RESULTS: Eleven studies were included. There were no differences between out-of-hours and in-hours acute cholecystectomy for rates of bile leakage, bile duct injury, overall postoperative complications, conversion to open cholecystectomy, operative duration, readmission, mortality, and postoperative length of stay. Higher rates of postoperative sepsis (odds ratio, 1.58; 95% confidence interval, 1.04-2.41; p = 0.03) and pneumonia (odds ratio, 1.55; 95% confidence interval, 1.06-2.26; p = 0.02) were observed following out-of-hours acute cholecystectomy on univariate meta-analysis, but not after the adjusted multivariate meta-analysis. Higher conversion rates were observed when out-of-hours cholecystectomy was performed in centers without an ASU.

CONCLUSION: This systematic review and meta-analysis has not shown an increased risk in overall or specific complications associated with out-of-hours compared with in-hours acute cholecystectomy. However, future studies should assess the potential impact of structural hospital factors, such as an ASU, on outcomes following out-of-hours acute cholecystectomy.

LEVEL OF EVIDENCE: Systematic Review and Meta-Analysis Study, Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Bhat S, Varghese C, Xu W, et al. Outcomes following out-of-hours acute cholecystectomy: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2022. PMID: 34554140. doi:10.1097/TA.0000000000003402

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。